Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/10435

Title:	Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)
Authors:	ASSOULINE, Sarit; BUCCHERI, Valeria; DELMER, Alain; GAIDANO, Gianluca; BREWSTER, Michael; CATALANI, Olivier; LI, Sai; MCINTYRE, Christine; SAYYED, Pakeeza; BADOUX, Xavier C.
Citation:	BLOOD, v.124, n.21, 2014
Appears in Collections:	Comunicações em Eventos - HC/ICHC Instituto Central - HC/ICHC

Files in This Item:

There are no files associated with this item.